No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Dexamethasone / administration & dosage
-
Dexamethasone / adverse effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Female
-
Hematologic Diseases / chemically induced
-
Humans
-
Hypocalcemia / chemically induced
-
Hyponatremia / chemically induced
-
Male
-
Middle Aged
-
Neoplasm, Residual
-
Oligopeptides / administration & dosage
-
Oligopeptides / adverse effects
-
Peripheral Nervous System Diseases / chemically induced
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Rituximab / administration & dosage
-
Treatment Outcome
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Young Adult
Substances
-
Oligopeptides
-
Rituximab
-
Vincristine
-
carfilzomib
-
Dexamethasone
-
Doxorubicin
-
Cyclophosphamide